May 04, 2026
Precision Oncology Market (By Product: Therapeutics, Diagnostics; By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Blood Cancer, Prostate Cancer, Others; By End-Use: Pharmaceutical & Biotechnology Companies, Hospita...
January 16, 2026
Market insights predict, the targeted therapy industry is expected to grow from USD 85.69 billion in 2025 to USD 166.53 billion by 2035, driven by a CAGR of 6.87%. In 2024, North America led the targeted therapy market (32%), with Asia Pacific set fo...
January 19, 2026
According to market projections, the oncology NGS sector is expected to grow from USD 589.01 million in 2025 to USD 2538.52 million by 2035, reflecting a CAGR of 15.73%. The demand for NGS in oncology is high due to growing cases of cancer and R&...
April 16, 2026
Orphan Oncology Market (By Therapy Type: Monoclonal Antibodies, Targeted Therapy, Immunotherapy, Chemotherapy, Cancer Vaccines; By Application: Oncology Treatment, Healthcare, Pharmaceuticals, Research, Clinical Trials; By Drug Modality: Biologi...
April 21, 2026
Forecasts suggest that the non-oncology precision medicine market will expand from USD 83.87 billion in 2024 to USD 193.16 billion by 2034, with a CAGR of 8.7% during this period. Non-Oncology Precision Medicine tailors treatments to individual patie...
April 21, 2026
Based on market forecasts, the global oncology market, projected at USD 225.05 billion in 2024, is expected to reach USD 748.17 billion by 2035, growing at a CAGR of 11.54% over the forecast period.The oncology market is expanding due to rising can...
May 25, 2026
Clinical Trial Services Market (By Service Line: Full-Service Clinical Development, Clinical Monitoring & Site Management, Data Management, Biostatistics & Programming, Central Lab & Biomarker Services, Functional Service Provider (FSP)/R...
April 21, 2026
Projections indicate the global genomics market will increase from USD 44.72 billion in 2025 to USD 198.99 billion by 2035, experiencing a CAGR of 16.1% over the next 10 years. Genomics is the study of genes and their functions. It focuses on underst...
January 23, 2026
Market insights predict, the proteinase K industry is expected to grow from USD 5.23 billion in 2025 to USD 11.87 billion by 2035, driven by a CAGR of 8.54%. The rising prevalence of infectious and other chronic disorders and the growing demand for e...
April 21, 2026
Projections indicate that, the global precision medicine software market will increase from USD 2.18 billion in 2025 to USD 7.14 billion by 2035, experiencing a CAGR of 12.6% over the next 10 years. The precision medicine software market is growing d...
January 07, 2026
According to forecasts, the U.S. liquid biopsy market was valued at USD 2.44 billion in 2025 and is projected to grow from USD 2.78 billion in 2026 to USD 8.90 billion by 2035, registering a CAGR of 13.82% (2026–2035). The U.S. liquid biopsy ma...
January 22, 2026
According to our insight, the U.S. antibody specificity testing market was valued at USD 343.71 million in 2025 and is projected to grow from USD 369.18 million in 2026 to nearly USD 702.49 billion by 2035, expanding at a CAGR of 7.41% during the for...
April 21, 2026
The next-generation metabolic therapies market is witnessing strong expansion and is expected to generate revenue in the hundreds of millions during the forecast period from 2026 to 2035, driven by rising cases of metabolic disorders such as obesity,...
April 16, 2026
Precision Medicine Market (By Product & Service: Biomarkers, Therapeutics, Sequencing & Genotyping, Companion Diagnostics, Data Analytics & Software, Services; By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Met...
April 24, 2026
North America Central Lab Market (By Service Type: Safety Testing, Specialty Testing & Biomarkers, Genomic & Molecular Testing, Pathology & Histology Services, Microbiology & Virology, Clinical Supply Chain & Biorepository; By The...
February 20, 2026
Projections indicate that, precision diagnostics & medicine industry is projected to rise from USD 162.88 billion in 2025 to USD 457.91 billion by 2035, reflecting a CAGR of 10.89% over the next decade. The integration of precision medicine into ...
April 21, 2026
Market insights predict, the human biofluid collection services industry is expected to grow from USD 1.48 billion in 2024 to USD 2.93 billion by 2034, driven by a CAGR of 7.08%. The notable importance of biofluids in clinical diagnostics and biomedi...
April 21, 2026
According to market projections, the hemophilia sector is expected to grow from USD 14.34 billion in 2024 to USD 27.27 billion by 2034, reflecting a CAGR of 6.64%. Hemophilia affects over 1.1M globally, often undiagnosed. Advances like gene therapy a...
April 21, 2026
Market insights predict the global blood based biomarkers industry will increase from USD 7.89 billion in 2024 to USD 15.78 billion by 2034, achieving a CAGR of 7.24%. In 2024, North America led the global blood-based biomarkers market, while Asia-Pa...
May 11, 2026
Pharma Cloud Services Market (By Service Type: SaaS, PaaS, IaaS; By Deployment Model: Public Cloud, Private Cloud, Hybrid Cloud; By Application: Clinical Trials, Drug Discovery, Manufacturing & Supply Chain, Regulatory & Compliance, Sales &am...
April 21, 2026
Heart Rate Monitor Market (By Product Type: Wearable Heart Rate Monitors, Chest Strap Monitors, Optical / Wrist-Based Monitors, Standalone / Portable Devices, Ancillary Tools & Accessories; By Deployment Type: On-Person / Wearable, Cloud-Based / ...
May 28, 2026
U.S. Breast Biopsy Devices Market (By Product: Needle-based Biopsy, Localized Wires, Guidance Systems, Biopsy Tables; By Technology: Vacuum-Assisted Biopsy, Core Needle Biopsy, Fine Needle Aspiration, Image-Guided Biopsy; By Guidance Technique: Ultra...
January 12, 2026
Based on market forecasts, the global AI in precision medicine market, projected at USD 3.44 billion in 2025, is expected to reach USD 33.45 billion by 2035, growing at a CAGR of 25.54% over the forecast period. AI is revolutionizing precision medici...
April 21, 2026
Market insights predict the global nanomedicine industry will increase from USD 241.49 billion in 2024 to USD 632.09 billion by 2034, achieving a CAGR of 10.1%. In 2024, North America led the market, while Asia-Pacific is the fastest-growing region. ...
June 01, 2026
Electron Brachytherapy Market (By Application: Skin Cancer, Basal cell carcinoma, Squamous cell carcinoma, Breast Cancer, Intraoperative electron brachytherapy for early-stage breast tumors, Gynecological Cancers, Cervical and endometrial cancer trea...
April 21, 2026
Market insights predict, the myasthenia gravis industry is expected to grow from USD 1.45 billion in 2024 to USD 2.95 billion by 2034, driven by a CAGR of 7.35%. In 2024, North America led the myasthenia gravis market, with Asia Pacific set for the f...
June 08, 2026
According to Rohan Patil, who specializes in U.S. medical foods markets, with years of experience in market research and industry analysis. My research shows that the U.S. medical foods Market is projected to grow from USD 10.52 billion in 2026 to US...
February 24, 2026
Based on our market forecasts, the pancreatic cancer precision medicine sector will expand from USD 815.63 million in 2025 to USD 4739.26 million by 2035, experiencing a CAGR of 19.24%....
April 21, 2026
Projections indicate that, AI in pharmaceuticals industry is projected to rise from USD 1.97 billion in 2025 to USD 21.51 billion by 2035, reflecting a CAGR of 27.01% over the next decade. The AI in the pharmaceutical market is growing as demand for ...
April 27, 2026
Cell And Gene Therapy Manufacturing Market (By Therapy: Allogeneic Cell Therapy, Autologous Cell Therapy; By Technology: Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Tec...
May 20, 2026
Tissue Regenerative Therapy Market (By Product Type: Cell Therapy, Gene Therapy, Tissue Engineering Platelet Rich Plasma; By Applications: Oncology, Musculoskeletal, Wound Care, Cardiovascular, Others; By Distribution Channel: Hospitals, Specialty Cl...
April 09, 2026
Optical Coherence Tomography Market (By Clinical Application: Ophthalmology, Cardiology, Dermatology & Oncology, Dentistry & ENT, Preclinical & Research Imaging; By Product Type / Form Factor: Desktop / Table-top Clinical OCT Systems, Por...
June 02, 2026
CRISPR Gene Editing Market (By Product: Products, Services; By Application: Biomedical; By End Use: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations; By Region: North America, Asia Paci...
April 17, 2026
Hyper-Personalized Medicine Market (By Product: Diagnostics, Therapeutics, Medical Care, Nutrition & Wellness; By Technology: Genomics, Proteomics, Bioinformatics, Metabolomics, Artificial Intelligence (AI); By Application: Oncology, Cardiology, ...
May 19, 2026
Separation Systems For Commercial Biotechnology Market (By Method: Conventional Methods, Chromatography, Flow Cytometry, Membrane Filtration, Electrophoresis, Centrifugation, Modern Methods, Microarray, Lab-on-a-chip, Magnetic Separation, Biochip; By...
January 09, 2026
Our market insight calculates, the cell and gene therapy bioanalytical testing services market was valued at USD 589.08 million in 2025 and is projected to grow from USD 632.55 million in 2026 to USD 1,200.62 million by 2035, registering a CAGR of 7....
April 21, 2026
Based on market forecasts, the global glycobiology market, projected at USD 0.65 billion in 2024, is expected to reach USD 2.63 billion by 2034, growing at a CAGR of 14.91% over the forecast period. Increasing biomedical research activities and enhan...
May 25, 2026
Other Animal-Based PDX Models; By Tumor Type: Gastrointestinal Cancer, Lung Cancer, Breast cancer, Hematological Cancer, Gynecological Cancer, Prostate Cancer, Brain Tumor, Melanoma, Others; By Application: Drug Discovery & Development, Personali...
April 21, 2026
According to market projections, the global NGS-based RNA-sequencing market, valued at USD 3.74 billion in 2024, is anticipated to reach USD 23.52 billion by 2034, growing at a CAGR of 20.1% over the next decade. The market is expanding due to its hi...
April 16, 2026
Aptamers Market (By Type: Nucleic Acid Aptamer, Peptide Aptamer; By Application: Diagnostics, Therapeutics, Research & Development, Others; By Region: North America, Asia Pacific, Europe, Latin America, Middle East and Africa) Global Analysis, Si...
April 21, 2026
Market insights predict the global life science lab equipment industry will increase from USD 57.71 billion in 2024 to USD 101.37 billion by 2034, achieving a CAGR of 5.84%. The market is expanding due to rising demand for advanced research tools in ...
March 27, 2026
Clinical Stage Biotechnology Market (By Product Type: Therapeutics, Diagnostics, Vaccines, Others; By Application: Oncology, Infectious Diseases, Cardiovascular Diseases, Neurology, Others; By Phase: Phase I, Phase II, Phase III; By End Us...
February 24, 2026
According to our projections, the U.S. life science sector is expected to grow from USD 31.58 billion in 2025 to USD 98.52 billion by 2035, reflecting a CAGR of 12.05%. The U.S. life science market is growing strong due to the rising demand for biolo...
April 29, 2026
Functional Medicine Diagnostic Market (By Product Type: Laboratory Diagnostic Kits, Instruments & Equipment, Software and Database; By Test Type: Genetic Testing, Nutritional Testing, Hormonal Testing, Immunological Testing; By End-User: Hospital...
April 27, 2026
Buoyancy Activated Cell Sorting (BACS) Market (By Product Type: Instruments, Consumables & Reagents, Software & Analytics; By Technology: Density Gradient-Based Sorting, Acoustic Buoyancy Sorting, Magnetically Buoyant-Assisted Sorting, Hybrid...
May 26, 2026
Deep Brain Stimulation Devices Market (By Product Type: Implantable Pulse Generator (IPG), Leads, Extensions; By Application: Parkinson’s Disease, Essential Tremor, Dystonia, Epilepsy, Obsessive-Compulsive Disorder (OCD), Others; By End User: H...
April 21, 2026
According to forecasts, the global endoscopic submucosal dissection (ESD) market will grow from USD 460 million in 2024 to USD 1022.86 million by 2034, with an expected CAGR of 8.35%. The rising prevalence of gastrointestinal disorders and technolo...
April 21, 2026
Accoring to research projection, the robotic dentistry market size to capture US$ 712.47 million in 2025 and is to soar US$ 1,458.12 million by 2030. The robotic dentistry market is transforming dental care with advanced robotic systems enhancing pre...
June 08, 2026
According to Shivani Zoting, who specializes in U.S. endobronchial ultrasound biopsy markets, with years of experience in market research and industry analysis. My research indicates that the U.S. Endobronchial Ultrasound Biopsy Market will grow from...
April 21, 2026
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, ...
April 21, 2026
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing ...
April 21, 2026
The global Pre-Dx oncology market is growing with rising cancer incidence and advanced early detection technologies. North America led with 45% share in 2024, while Asia Pacific is fastest-growing. Liquid biopsy tests accounted for 40% revenue, MCED ...
April 21, 2026
According to market projections, the radiation oncology sector is expected to grow from USD 12.45 billion in 2025 to USD 36.78 billion by 2035, reflecting a CAGR of 11.44%. The rising prevalence of cancer and technological advancements drive the glob...
April 21, 2026
Market insights predict the APAC clinical trials industry will increase from USD 18.87 billion in 2025 to USD 41.33 billion by 2035, achieving a CAGR of 7.16%. The market is growing due to the increasing demand for new and effective therapies and ris...
April 21, 2026
Projections indicate that, GMP peptides industry is projected to rise from USD 1.3 billion in 2024 to USD 2.9 billion by 2034, reflecting a CAGR of 8.35% over the next decade. The growing demand for peptide drugs and technological advancements drives...
February 19, 2026
According to market projections, the Europe pharmaceutical market, valued at USD 467.59 billion in 2024, is anticipated to reach USD 820.05 billion by 2034, growing at a CAGR of 5.78% over the next decade. The Europe pharmaceutical market is expandin...
April 21, 2026
Based on market forecasts, the U.S. oncology sector will expand from USD 72.79 billion in 2024 to USD 211.78 billion by 2034, experiencing a CAGR of 11.75%. The West region led the market due to the vital contribution of California in the oncology ...
April 24, 2026
Brain Cancer Market (By Product/Solution Type: Therapeutic Treatments, Diagnostic Imaging, Surgical Devices, Supportive Care Products; By Treatment Modality: Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery, Tumor Treating Fi...
April 21, 2026
According to market projections, the oncology drug discovery sector is growing due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies. Advances in genomics and biotechnology are accelerating the development ...
April 02, 2026
AI In Oncology Market ( By Component: Software Solutions, Hardware, Services; By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer Brain Tumors, Others; By End-User: Hospitals, Pharmaceutical Companies, Research Institutes, ...
January 06, 2026
Based on market forecasts, the bRo5 molecules market is witnessing rapid expansion due to increasing pharmaceutical R&D investments, growing adoption of AI-assisted drug discovery platforms, and rising oncology and CNS disorder prevalence. The ma...
April 21, 2026
The veterinary oncology market reached USD 1.58 billion in 2024 and is set to grow to USD 1.77 billion in 2025, reaching USD 4.86 billion by 2034 at a CAGR of 12.14%. The report covers market segmentation by animal, therapy, and cancer type, regional...
April 21, 2026
Based on market forecasts, the U.S. oncology molecular diagnostics sector will expand from USD 810 million in 2024 to USD 2570.17 million by 2034, experiencing a CAGR of 12.24%. In 2024, breast cancer dominated the market, while liver cancer is expec...
April 21, 2026
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
April 21, 2026
Market insights predict, the oncology automation industry is expected to grow from USD 2.82 billion in 2024 to USD 7.77 billion by 2034, driven by a CAGR of 10.68%. The oncology automation market is growing due to rising cases of cancer, leading to a...
April 21, 2026
Market insights predict the global clinical trial imaging industry will increase from USD 2.41 billion in 2024 to USD 5.58 billion by 2034, achieving a CAGR of 8.8%. The market is growing due to the increasing adoption of advanced imaging technologie...
January 13, 2026
Market insights predict the global hemato-oncology testing industry will increase from USD 4 billion in 2025 to USD 12.88 billion by 2035, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the to...
June 10, 2026
According to Rohan Patil, who specializes in Healthcare and Life Sciences market research and oncology diagnostics analysis, with 5+ years of experience in market research and industry analysis, the oncology biomarker market demonstrates strong expan...
January 12, 2026
Projections indicate that, surgical microscope industry is projected to rise from USD 1.52 billion in 2025 to USD 4.31 billion by 2035, reflecting a CAGR of 10.97% over the next decade.Investments in healthcare infrastructure, especially in emergin...
March 18, 2026
According to market projections, the oncology devices sector is expected to grow from USD 177.17 billion in 2025 to USD 914.79 billion by 2035, reflecting a CAGR of 17.84%. The increasing prevalence and awareness of cancer and the shift towards perso...
April 21, 2026
According to market projections, the U.S. oncology drugs sector is expected to grow from USD 95.69 billion in 2024 to USD 246.85 billion by 2034, reflecting a CAGR of 9.94%. The extensive research, scientific innovations, and the market penetration...
April 14, 2026
Brain Tumor Drugs Market (By Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, Others; By Indication: Pituitary, Meningioma, Glioma, Others; By Distribution Channel: Hospital Pharmacy, Retail & Online Pharmacy, By Region: North America, Asi...
April 21, 2026
The multiple modalities in oncology market is expanding due to increasing tumor heterogeneity as well as growing treatment approaches. North America led the market due to the presence of the advanced healthcare sector....
April 21, 2026
The microfluidics in oncology market is growing due to this system offering more sensitive and precise detection of cancer biomarkers and therapeutic approaches than traditional assays....
April 08, 2026
Oncology Molecular Diagnostics Market ( By Type: Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer Others; By Product: Instruments, Reagents, Others; By Technology: PCR, In-situ...
May 18, 2026
Oncology Companion Diagnostic Market (By Product & Services: Product, Software; By Technology: Polymerase Chain Reaction, Next-generation Sequencing, Immunohistochemistry, In Situ Hybridization (ISH)/Fluorescence In Situ Hybridization, Other Tech...
April 21, 2026
The rising prevalence of cancer and technological advancements are the major growth factors of the market. North America dominated the global market, owing to favorable government initiatives and increasing investments....
May 27, 2026
Oncology Clinical Trial Market (By Phase: Phase I, Phase II, Phase III, Phase IV; By Study Design: Interventional Trials, Observational Trials, Expanded Access Trials; By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Bl...
April 21, 2026
Market insights predict, the investigational new drug CDMO industry is expected to grow from USD 5.66 billion in 2025 to USD 11.10 billion by 2035, driven by a CAGR of 6.97%. The investigational new drug CDMO market is expanding due to increasing dev...
April 21, 2026
Rising advantages of AI and ML in the world are reducing timelines, cost-effective approaches in drug discovery and clinical trials are driving the global market. North America was dominant in the market due to technological advancements by using AI ...
May 21, 2026
AI in Oncology for Analytical Solutions Market (By Component: Data Licensing Services, Software Solutions, Analytics and Other Services; By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Kidney Cancer, Non-H...
April 21, 2026
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
April 21, 2026
Based on market forecasts, the global tele-oncology market, projected at USD 4.74 billion in 2024, is expected to reach USD 20.48 billion by 2034, growing at a CAGR of 15.76% over the forecast period. A sure sign of the adoption of advanced he...
April 21, 2026
Market insights predict the global radionuclide drug conjugates (RDC) industry will increase from USD 3.24 billion in 2024 to USD 8.87 billion by 2034, achieving a CAGR of 10.54%. The global radionuclide drug conjugates (RDC) market is growing stro...
February 25, 2026
U.S. AI in Oncology Market (By Component: Software Solutions, Hardware, Services; By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumors & Others; By Therapeutic Area: Diagnostics, Drug Discovery & Resear...
April 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
February 17, 2026
Our projections indicate that, the oncology clinical trial monitor market was valued at USD 15.76 billion in 2026 and is projected to reach USD 25.6 billion by 2035, expanding at a CAGR of 5.54% (2026–2035)....
April 21, 2026
Based on market forecasts, the global radiotherapy market, projected at USD 7.88 billion in 2024, is expected to reach USD 15.63 billion by 2034, growing at a CAGR of 7.09% over the forecast period. The market is expanding due to the increasing glo...
April 21, 2026
The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. ...
May 20, 2026
Cell and Gene Therapy for Oncology Market (By Therapy Type: Cell Therapy, Gene Therapy, Non-Viral Gene Therapy, Gene Editing Therapy; By Cancer Type: Hematological Malignancies, Solid Tumors; By Therapy Source: Autologous Therapies, Allogeneic Therap...
April 21, 2026
According to market projections, the immuno-oncology drugs sector is expected to grow from USD 94 billion in 2024 to USD 421.27 billion by 2034, reflecting a CAGR of 16.34%. Across the globe, a rising number of cancer patients is associated with the ...
April 21, 2026
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
April 21, 2026
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...